E2307 - Eisai
Major R&D Pipeline - Eisai (Eisai Press Release) - Feb 2, 2016 - "Development has been discontinued for the Alzheimer’s disease indication for E2307 at the Phase I stage." 
Discontinued • Alzheimer's Disease
http://www.eisai.com/pdf/eir/erepo/epipeline.pdf
 
Feb 2, 2016
 
.........................................